TY - JOUR
T1 - Modelling amyotrophic lateral sclerosis in rodents
AU - Todd, Tiffany W.
AU - Petrucelli, Leonard
N1 - Publisher Copyright:
© 2022, Springer Nature Limited.
PY - 2022/4
Y1 - 2022/4
N2 - The efficient study of human disease requires the proper tools, one of the most crucial of which is an accurate animal model that faithfully recapitulates the human condition. The study of amyotrophic lateral sclerosis (ALS) is no exception. Although the majority of ALS cases are considered sporadic, most animal models of this disease rely on genetic mutations identified in familial cases. Over the past decade, the number of genes associated with ALS has risen dramatically and, with each new genetic variant, there is a drive to develop associated animal models. Rodent models are of particular importance as they allow for the study of ALS in the context of a living mammal with a comparable CNS. Such models not only help to verify the pathogenicity of novel mutations but also provide critical insight into disease mechanisms and are crucial for the testing of new therapeutics. In this Review, we aim to summarize the full spectrum of ALS rodent models developed to date.
AB - The efficient study of human disease requires the proper tools, one of the most crucial of which is an accurate animal model that faithfully recapitulates the human condition. The study of amyotrophic lateral sclerosis (ALS) is no exception. Although the majority of ALS cases are considered sporadic, most animal models of this disease rely on genetic mutations identified in familial cases. Over the past decade, the number of genes associated with ALS has risen dramatically and, with each new genetic variant, there is a drive to develop associated animal models. Rodent models are of particular importance as they allow for the study of ALS in the context of a living mammal with a comparable CNS. Such models not only help to verify the pathogenicity of novel mutations but also provide critical insight into disease mechanisms and are crucial for the testing of new therapeutics. In this Review, we aim to summarize the full spectrum of ALS rodent models developed to date.
UR - http://www.scopus.com/inward/record.url?scp=85125951710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125951710&partnerID=8YFLogxK
U2 - 10.1038/s41583-022-00564-x
DO - 10.1038/s41583-022-00564-x
M3 - Review article
C2 - 35260846
AN - SCOPUS:85125951710
SN - 1471-0048
VL - 23
SP - 231
EP - 251
JO - Nature Reviews Neuroscience
JF - Nature Reviews Neuroscience
IS - 4
ER -